---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-067856"
form_type: "8-K"
ticker: "REPL"
cik: "0001737953"
company_name: "Replimune Group, Inc."
filed_at: "2023-06-05T23:59:59+00:00"
generated_at: "2026-06-14T07:27:46.917951+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Replimune appoints Veleka Peeples-Dyer to Board of Directors, effective June 1, 2023

## Summary
- Veleka Peeples-Dyer appointed to Board as tenth member, filling vacancy from Board size increase.
- She also joins the Audit Committee, replacing Dieter Weinand; receives annual retainers of $45,000 (Board) and $10,000 (Audit).
- Granted nonqualified stock option for 50,400 shares at $18.48 strike, vesting 25% after one year then monthly over 24 months.
- Ms. Peeples-Dyer brings over 24 years of life sciences legal and compliance experience, including executive roles at biopharma companies.

## SEC filing metadata
- accession: 0001104659-23-067856
- form_type: 8-K
- ticker: REPL
- cik: 0001737953
- company_name: Replimune Group, Inc.
- filed_at: 2023-06-05T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1737953/000110465923067856/0001104659-23-067856-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1737953/000110465923067856/tm2317684d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-067856
- JSON: https://secwatch.observer/filing/0001104659-23-067856.json
- Plain text: https://secwatch.observer/filing/0001104659-23-067856.txt

## Key facts
- Executive change
  Veleka Peeples-Dyer was appointed as Director at Replimune Group, Inc..
  - Action: appointed
  - Role: Director
  source text: On June 1, 2023, based on the recommendation of the Nominating and Corporate Governance Committee of the Board of Directors (the "Board") of Replimune Group, Inc. (the "Company"), the Board appointed Veleka Peeples-Dyer to serve as a member of the Board, effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1737953/000110465923067856/0001104659-23-067856-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.